US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist
  • 125.650
  • +0.650+0.52%
Close Nov 22 16:00 ET
  • 125.650
  • 0.0000.00%
Post 20:01 ET
12.72BMarket Cap33.51P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
24.72%622.1M
30.37%590.2M
22.57%515.3M
26.76%1.89B
25.05%515.2M
28.59%498.8M
19.70%452.7M
35.35%420.4M
31.34%1.49B
32.05%412M
Operating revenue
24.72%622.1M
30.37%590.2M
22.57%515.3M
26.76%1.89B
25.05%515.2M
28.59%498.8M
19.70%452.7M
35.35%420.4M
31.34%1.49B
32.05%412M
Cost of revenue
-28.57%8M
-20.00%9.2M
-11.76%7.5M
71.12%39.7M
10.39%8.5M
83.61%11.2M
139.58%11.5M
84.78%8.5M
62.24%23.2M
87.80%7.7M
Gross profit
25.94%614.1M
31.69%581M
23.28%507.8M
26.06%1.85B
25.33%506.7M
27.71%487.6M
18.16%441.2M
34.61%411.9M
30.94%1.47B
31.31%404.3M
Operating expense
23.93%429.3M
17.82%433.1M
5.31%402.5M
19.41%1.45B
18.44%356.4M
17.82%346.4M
15.34%367.6M
26.18%382.2M
33.48%1.22B
23.37%300.9M
Selling and administrative expenses
14.74%234.3M
9.11%242M
0.16%243.1M
17.92%887.6M
19.68%218.9M
9.61%204.2M
21.33%221.8M
20.93%242.7M
29.04%752.7M
16.87%182.9M
Research and development costs
37.13%195M
31.07%191.1M
14.27%159.4M
21.82%565M
16.53%137.5M
32.03%142.2M
7.28%145.8M
36.50%139.5M
41.36%463.8M
35.01%118M
Operating profit
30.88%184.8M
100.95%147.9M
254.55%105.3M
58.55%394.8M
45.36%150.3M
60.82%141.2M
34.55%73.6M
858.06%29.7M
19.83%249M
61.56%103.4M
Net non-operating interest income expense
-49.7M
-8,063.64%-89.8M
35.21%-4.6M
0
57.69%-1.1M
72.48%-7.1M
83.33%-1.1M
Non-operating interest expense
----
--49.7M
8,063.64%89.8M
-35.21%4.6M
----
----
--0
-57.69%1.1M
-72.48%7.1M
-83.33%1.1M
Other net income (expense)
121.48%5.5M
-99.17%400K
114.40%19M
-107.50%-58.1M
236.54%52.5M
-326.55%-25.6M
163.32%48M
-731.10%-131.9M
65.26%-28M
121.91%15.6M
Gain on sale of security
125.39%6.5M
-93.96%2.9M
108.33%25M
104.29%85.8M
236.54%52.5M
-326.55%-25.6M
927.59%48M
-42.58%12M
70.04%42M
-46.39%15.6M
Special income (charges)
---1M
---2.5M
95.83%-6M
-105.57%-143.9M
--0
--0
--0
---143.9M
33.52%-70M
--0
-Less:Other special charges
--1M
--2.5M
-95.83%6M
105.57%143.9M
--0
----
----
--143.9M
-33.52%70M
--0
Income before tax
64.62%190.3M
-18.91%98.6M
133.40%34.5M
55.26%332.1M
68.11%198.2M
18.08%115.6M
621.89%121.6M
-582.71%-103.3M
110.95%213.9M
954.35%117.9M
Income tax
86.15%60.5M
28.74%33.6M
66.67%-8.9M
38.72%82.4M
74.74%50.5M
10.54%32.5M
507.81%26.1M
-456.00%-26.7M
403.39%59.4M
544.62%28.9M
Net income
56.20%129.8M
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
72.43%154.5M
1,319.18%89M
Net income continuous Operations
56.20%129.8M
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
72.43%154.5M
1,319.18%89M
Minority interest income
Net income attributable to the parent company
56.20%129.8M
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
72.43%154.5M
1,319.18%89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
56.20%129.8M
-31.94%65M
156.66%43.4M
61.62%249.7M
65.96%147.7M
21.31%83.1M
665.09%95.5M
-651.08%-76.6M
72.43%154.5M
1,319.18%89M
Basic earnings per share
50.59%1.28
-34.69%0.64
154.43%0.43
59.01%2.56
63.04%1.5
18.06%0.85
644.44%0.98
-626.67%-0.79
69.47%1.61
1,250.00%0.92
Diluted earnings per share
51.22%1.24
-33.68%0.63
153.16%0.42
58.33%2.47
63.64%1.44
18.84%0.82
627.78%0.95
-664.29%-0.79
69.57%1.56
1,200.00%0.88
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 24.72%622.1M30.37%590.2M22.57%515.3M26.76%1.89B25.05%515.2M28.59%498.8M19.70%452.7M35.35%420.4M31.34%1.49B32.05%412M
Operating revenue 24.72%622.1M30.37%590.2M22.57%515.3M26.76%1.89B25.05%515.2M28.59%498.8M19.70%452.7M35.35%420.4M31.34%1.49B32.05%412M
Cost of revenue -28.57%8M-20.00%9.2M-11.76%7.5M71.12%39.7M10.39%8.5M83.61%11.2M139.58%11.5M84.78%8.5M62.24%23.2M87.80%7.7M
Gross profit 25.94%614.1M31.69%581M23.28%507.8M26.06%1.85B25.33%506.7M27.71%487.6M18.16%441.2M34.61%411.9M30.94%1.47B31.31%404.3M
Operating expense 23.93%429.3M17.82%433.1M5.31%402.5M19.41%1.45B18.44%356.4M17.82%346.4M15.34%367.6M26.18%382.2M33.48%1.22B23.37%300.9M
Selling and administrative expenses 14.74%234.3M9.11%242M0.16%243.1M17.92%887.6M19.68%218.9M9.61%204.2M21.33%221.8M20.93%242.7M29.04%752.7M16.87%182.9M
Research and development costs 37.13%195M31.07%191.1M14.27%159.4M21.82%565M16.53%137.5M32.03%142.2M7.28%145.8M36.50%139.5M41.36%463.8M35.01%118M
Operating profit 30.88%184.8M100.95%147.9M254.55%105.3M58.55%394.8M45.36%150.3M60.82%141.2M34.55%73.6M858.06%29.7M19.83%249M61.56%103.4M
Net non-operating interest income expense -49.7M-8,063.64%-89.8M35.21%-4.6M057.69%-1.1M72.48%-7.1M83.33%-1.1M
Non-operating interest expense ------49.7M8,063.64%89.8M-35.21%4.6M----------0-57.69%1.1M-72.48%7.1M-83.33%1.1M
Other net income (expense) 121.48%5.5M-99.17%400K114.40%19M-107.50%-58.1M236.54%52.5M-326.55%-25.6M163.32%48M-731.10%-131.9M65.26%-28M121.91%15.6M
Gain on sale of security 125.39%6.5M-93.96%2.9M108.33%25M104.29%85.8M236.54%52.5M-326.55%-25.6M927.59%48M-42.58%12M70.04%42M-46.39%15.6M
Special income (charges) ---1M---2.5M95.83%-6M-105.57%-143.9M--0--0--0---143.9M33.52%-70M--0
-Less:Other special charges --1M--2.5M-95.83%6M105.57%143.9M--0----------143.9M-33.52%70M--0
Income before tax 64.62%190.3M-18.91%98.6M133.40%34.5M55.26%332.1M68.11%198.2M18.08%115.6M621.89%121.6M-582.71%-103.3M110.95%213.9M954.35%117.9M
Income tax 86.15%60.5M28.74%33.6M66.67%-8.9M38.72%82.4M74.74%50.5M10.54%32.5M507.81%26.1M-456.00%-26.7M403.39%59.4M544.62%28.9M
Net income 56.20%129.8M-31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M72.43%154.5M1,319.18%89M
Net income continuous Operations 56.20%129.8M-31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M72.43%154.5M1,319.18%89M
Minority interest income
Net income attributable to the parent company 56.20%129.8M-31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M72.43%154.5M1,319.18%89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 56.20%129.8M-31.94%65M156.66%43.4M61.62%249.7M65.96%147.7M21.31%83.1M665.09%95.5M-651.08%-76.6M72.43%154.5M1,319.18%89M
Basic earnings per share 50.59%1.28-34.69%0.64154.43%0.4359.01%2.5663.04%1.518.06%0.85644.44%0.98-626.67%-0.7969.47%1.611,250.00%0.92
Diluted earnings per share 51.22%1.24-33.68%0.63153.16%0.4258.33%2.4763.64%1.4418.84%0.82627.78%0.95-664.29%-0.7969.57%1.561,200.00%0.88
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data